Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrinology Research Centre 2018-12-01
Serie:Ожирение и метаболизм
Soggetti:
diabetes type 2
obesity
glucagon-like peptide-1 receptor agonists
glucagon-like peptide-1
ghrelin
food behavior
Accesso online:https://www.omet-endojournals.ru/jour/article/view/9584
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi